Our Products

新藥產品

First-in-Class Oral Dosage Hec1/Nek2 Inhibitor

Novel Targeting Small Molecule-drug Conjugate (SN-38)

Novel Multi-targeted Tyrosine Kinase Inhibitor (TKI)

Novel Targeting Small Molecule-drug Conjugate (DM-1)

Pipeline 

研發進度

Scroll to Top